The NAFLD GWAS of the UK Biobank included 1,664 NAFLD cases and 400,055 controls identified only 2 regions robustly associated with NAFLD (PNPLA3 and PBX4/TM6SF2). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.